Tabalumab Biosimilar – Anti-TNFSF13B, CD257 mAb – Research Grade

Reference:
Size

,

Isotype

IgG4, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameTabalumab Biosimilar - Anti-TNFSF13B, CD257 mAb - Research Grade
SourceCAS 1143503-67-6
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsTabalumab,LY2127399,TNFSF13B, CD257,anti-TNFSF13B, CD257
ReferencePX-TA1275
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody

Description of Tabalumab Biosimilar - Anti-TNFSF13B, CD257 mAb - Research Grade

General information on Anti-TNFSF13B/CD257[Homo sapiens] (Tabalumab) Monoclonal Antibody

Tabalumab has been investigated for the treatment of Autoimmune Disease, Rheumatoid Arthritis, Kidney Failure, Chronic, Connective Tissue Disease, and Systemic Lupus Erythematosus.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Tabalumab Biosimilar – Anti-TNFSF13B, CD257 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD257 / BAFF / TNFSF13B, C-His, recombinant protein
Antigen

CD257 / BAFF / TNFSF13B, C-His, recombinant protein

PX-P5600 420€
CD257 Recombinant Protein
Antigen

CD257 Recombinant Protein

PX-P4112 420€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products